Cargando…
PB2399: BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428913/ http://dx.doi.org/10.1097/01.HS9.0000976308.74870.ea |
_version_ | 1785090584575213568 |
---|---|
author | Zhang, Xudong Qiao, Honghan Chai, Xiaofei Gao, Xue MA, Rongjun LI, Yufu Zhu, Zunmin Zhang, Mingzhi |
author_facet | Zhang, Xudong Qiao, Honghan Chai, Xiaofei Gao, Xue MA, Rongjun LI, Yufu Zhu, Zunmin Zhang, Mingzhi |
author_sort | Zhang, Xudong |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10428913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104289132023-08-17 PB2399: BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY Zhang, Xudong Qiao, Honghan Chai, Xiaofei Gao, Xue MA, Rongjun LI, Yufu Zhu, Zunmin Zhang, Mingzhi Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428913/ http://dx.doi.org/10.1097/01.HS9.0000976308.74870.ea Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Zhang, Xudong Qiao, Honghan Chai, Xiaofei Gao, Xue MA, Rongjun LI, Yufu Zhu, Zunmin Zhang, Mingzhi PB2399: BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY |
title | PB2399: BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY |
title_full | PB2399: BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY |
title_fullStr | PB2399: BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY |
title_full_unstemmed | PB2399: BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY |
title_short | PB2399: BRENTUXIMAB VEDOTIN IN TREATING CHINESE PATIENTS WITH LYMPHOMA:A MULTICENTER,REAL-WORLD STUDY |
title_sort | pb2399: brentuximab vedotin in treating chinese patients with lymphoma:a multicenter,real-world study |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428913/ http://dx.doi.org/10.1097/01.HS9.0000976308.74870.ea |
work_keys_str_mv | AT zhangxudong pb2399brentuximabvedotinintreatingchinesepatientswithlymphomaamulticenterrealworldstudy AT qiaohonghan pb2399brentuximabvedotinintreatingchinesepatientswithlymphomaamulticenterrealworldstudy AT chaixiaofei pb2399brentuximabvedotinintreatingchinesepatientswithlymphomaamulticenterrealworldstudy AT gaoxue pb2399brentuximabvedotinintreatingchinesepatientswithlymphomaamulticenterrealworldstudy AT marongjun pb2399brentuximabvedotinintreatingchinesepatientswithlymphomaamulticenterrealworldstudy AT liyufu pb2399brentuximabvedotinintreatingchinesepatientswithlymphomaamulticenterrealworldstudy AT zhuzunmin pb2399brentuximabvedotinintreatingchinesepatientswithlymphomaamulticenterrealworldstudy AT zhangmingzhi pb2399brentuximabvedotinintreatingchinesepatientswithlymphomaamulticenterrealworldstudy |